Cosmo Pharmaceuticals N.V. (CMOPF)

Market Cap	902.30M
Revenue (ttm)	276.21M
Net Income (ttm)	137.94M
Shares Out	n/a
EPS (ttm)	8.40
PE Ratio	6.54
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	200
Average Volume	215
Open	55.00
Previous Close	62.80
Day's Range	55.00 - 55.00
52-Week Range	55.00 - 95.00
Beta	1.38
RSI	34.80
Earnings Date	Jul 23, 2025

About Cosmo Pharmaceuticals

Cosmo Pharmaceuticals N.V. focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide. The company offers GI Genius, a computer-assisted system that uses artificial intelligence in real time to detect colorectal lesions; Winlevi, a prescription medicine used on the skin to treat acne vulgaris; Lialda/Mezavant/Mesavancol, a once-daily mesalamine tablet approved to help get active, mild to moderate ulcerative colitis into remission; Uceris/Cortiment, an oral tablet formulation that delive...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1997
• Employees: 322
• Stock Exchange: OTCMKTS
• Ticker Symbol: CMOPF

Financial Performance

Financial numbers in EUR